Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non–Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies

医学 聚乙二醇非格司亭 肿瘤科 肺癌 内科学 乳腺癌 化疗 卵巢癌 癌症 非霍奇金淋巴瘤 菲格拉斯汀 粒细胞集落刺激因子
作者
Howard A. Burris,Chandra Prakash Belani,Peter Andrew Kaufman,Alan N. Gordon,Lee Steven Schwartzberg,Warren S. Paroly,Seta Shahin,Lyndah K. Dreiling,Alan Saven
出处
期刊:Journal of Oncology Practice [American Society of Clinical Oncology]
卷期号:6 (3): 133-140 被引量:103
标识
DOI:10.1200/jop.091094
摘要

PURPOSE: To compare data on severe (grade 4) neutropenia duration and febrile neutropenia incidence in patients receiving chemotherapy with pegfilgrastim administered the same day or 24 hours after chemotherapy. PATIENTS AND METHODS: These were similar, randomized, double-blind phase II noninferiority studies of patients with lymphoma or non-small-cell lung (NSCLC), breast, or ovarian cancer. Each study was analyzed separately. The primary end point in each study was cycle-1 severe neutropenia duration. Approximately 90 patients per study were to be randomly assigned at a ratio of 1:1 to receive pegfilgrastim 6 mg once per cycle on the day of chemotherapy or the day after (with placebo on the alternate day). RESULTS: In four studies, 272 patients received chemotherapy and one or more doses of pegfilgrastim (133 same day, 139 next day). Three studies (breast, lymphoma, NSCLC) enrolled an adequate number of patients for analysis. However, in the NSCLC study, the neutropenic rate was lower than expected (only two patients per arm experienced grade 4 neutropenia). In the breast cancer study, the mean cycle-1 severe neutropenia duration was 1.2 days (95% confidence limit [CL], 0.7 to 1.6) longer in the same-day compared with the next-day group (mean, 2.6 v 1.4 days). In the lymphoma study, the mean cycle-1 severe neutropenia duration was 0.9 days (95% CL, 0.3 to 1.4) longer in the same-day compared with the next-day group (mean, 2.1 v 1.2 days). In the breast and lymphoma studies, the absolute neutrophil count profile for same-day patients was earlier, deeper, and longer compared with that for next-day patients, although the results indicate that same-day administration was statistically noninferior to next-day administration according to neutropenia duration. CONCLUSION: For patients receiving pegfilgrastim with chemotherapy, pegfilgrastim administered 24 hours after chemotherapy completion is recommended.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
是奶柚啊发布了新的文献求助10
刚刚
刚刚
FashionBoy的应助被番薯区丧彪采纳,获得10
1秒前
1秒前
光亮蛋挞完成签到 ,获得积分10
1秒前
从容紫寒发布了新的文献求助10
1秒前
2秒前
2秒前
2秒前
蓝天的应助被阎罗恶煞采纳,获得10
2秒前
简隋英发布了新的文献求助20
2秒前
3秒前
7777完成签到,获得积分20
3秒前
嘻嘻发布了新的文献求助10
3秒前
3秒前
朴实归尘发布了新的文献求助10
4秒前
未来发布了新的文献求助10
4秒前
可爱的函函的应助被无私柠檬采纳,获得10
5秒前
再睡亿分钟完成签到,获得积分10
5秒前
6秒前
6秒前
三顾毛驴完成签到 ,获得积分10
6秒前
7秒前
52222完成签到,获得积分20
7秒前
7秒前
molihuakai的应助被康子浩采纳,获得10
7秒前
7秒前
小狗发布了新的文献求助10
8秒前
52222发布了新的文献求助10
9秒前
汉堡包的应助被顺利的蘑菇采纳,获得10
9秒前
李健的应助被zzq采纳,获得10
9秒前
9秒前
阔达的千凝完成签到,获得积分20
10秒前
10秒前
鳗鱼元风的应助被聪明的柠檬采纳,获得10
10秒前
今后的应助被刘66采纳,获得10
10秒前
11秒前
11秒前
大模型的应助被大胆冰棍采纳,获得10
12秒前
领导范儿的应助被大虫子采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163614
求助须知:如何正确求助?哪些是违规求助? 9557702
关于积分的说明 21741573
捐赠科研通 7754282
什么是DOI,文献DOI怎么找? 3428275
关于科研通互助平台的介绍 2552989
邀请新用户注册赠送积分活动 2472923